Background: The literature supporting telehealth management is growing accelerated by the COVID-pandemic. We hypothesize that there are risks of adverse events associated with telehealth interventions.
Methods: A review of PubMed (including MEDLINE), Embase, ISI (Web of Science), VHL/GHL, Scopus, Science Direct, and PsycINFO was conducted for all adverse events associated with telehealth from January 1, 1960 to March 1, 2021. This systematic review and meta-analyses were conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines.
Results: Of 5,144 citations 78 published studies met criteria for quality evaluation and underwent full text abstraction including the qualitative synthesis. Of the 78 included studies 8 were included in the quantitative synthesis resulting in 2 meta-analyses. The results of the meta-analysis suggest that monitoring patients using telehealth techniques is associated with 40% lower mortality risks among patients suffering from heart failure, compared to those who received traditional care. The results of the random-effects meta-analysis showed the pooled relative risk of mortality to be 0.60, indicating that patients that underwent telemonitoring had a lower mortality risk compared with the patients that underwent usual care. Among patients with heart implants, patients who received telemonitoring had a 35% lower mortality risk compared to patients receiving traditional care.
Conclusions: While RCTs of telehealth interventions demonstrate enhanced patient outcomes in a number of studies and pave the way to evidence-based practice, the heterogeneity of the research questions suggest an important need for more complementary studies with consistent outcome assessments.
References
1.
Wherton J, Shaw S, Papoutsi C, Seuren L, Greenhalgh T. Guidance on the introduction and use of video consultations during COVID-19: important lessons from qualitative research. BMJ Leader. 2020;4(3):120–3.
2.
Catalyst N. What is telehealth? NEJM Catalyst. 2018;(1).
3.
Salisbury C, O’Cathain A, Edwards L, Thomas C, Gaunt D, Hollinghurst S, et al. Effectiveness of an integrated telehealth service for patients with depression: a pragmatic randomised controlled trial of a complex intervention. The Lancet Psychiatry. 2016;3(6):515–25.
4.
Schutte-Rodin S. Telehealth, Telemedicine, and Obstructive Sleep Apnea. Sleep Medicine Clinics. 2020;15(3):359–75.
5.
Wong MYZ, Gunasekeran DV, Nusinovici S, Sabanayagam C, Yeo KK, Cheng CY, et al. Telehealth Demand Trends During the COVID-19 Pandemic in the Top 50 Most Affected Countries: Infodemiological Evaluation. JMIR Public Health and Surveillance. 2021;7(2):e24445.
6.
Perle JG, Nierenberg B. How Psychological Telehealth Can Alleviate Society’s Mental Health Burden: A Literature Review. Journal of Technology in Human Services. 2013;31(1):22–41.
7.
Shafiee Hanjani L, Caffery LJ, Freeman CR, Peeters G, Peel NM. A scoping review of the use and impact of telehealth medication reviews. Research in Social and Administrative Pharmacy. 2020;16(8):1140–53.
8.
Agboola S, Kvedar J, Target S. Telemedicine and patient safety: AHRQ Patient Safety Network. 2016;
9.
Koehler F, Winkler S, Schieber M, Sechtem U, Stangl K, Böhm M, et al. Telemedical Interventional Monitoring in Heart Failure (TIM‐HF), a randomized, controlled intervention trial investigating the impact of telemedicine on mortality in ambulatory patients with heart failure: study design. European Journal of Heart Failure. 2010;12(12):1354–62.
10.
Balduzzi S, Rücker G, Schwarzer G. How to perform a meta-analysis with R: a practical tutorial. Evidence Based Mental Health. 2019;22(4):153–60.
11.
Boriani G, Da Costa A, Quesada A, Ricci RP, Favale S, Boscolo G, et al. Effects of remote monitoring on clinical outcomes and use of healthcare resources in heart failure patients with biventricular defibrillators: results of the MORE‐CARE multicentre randomized controlled trial. European Journal of Heart Failure. 2016;19(3):416–25.
12.
Hindricks G, Taborsky M, Glikson M, Heinrich U, Schumacher B, Katz A, et al. Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. The Lancet. 2014;384(9943):583–90.
13.
Mabo P, Victor F, Bazin P, Ahres S, Babuty D, Da Costa A, et al. A randomized trial of long-term remote monitoring of pacemaker recipients (The COMPAS trial). European Heart Journal. 2011;33(9):1105–11.
14.
Guedon-Moreau L, Lacroix D, Sadoul N, Clementy J, Kouakam C, Hermida JS, et al. A randomized study of remote follow-up of implantable cardioverter defibrillators: safety and efficacy report of the ECOST trial. European Heart Journal. 2012;34(8):605–14.
15.
García-Fernández FJ, Osca Asensi J, Romero R, Fernández Lozano I, Larrazabal JM, Martínez Ferrer J, et al. Safety and efficiency of a common and simplified protocol for pacemaker and defibrillator surveillance based on remote monitoring only: a long-term randomized trial (RM-ALONE). European Heart Journal. 2019;40(23):1837–46.
16.
Landolina M, Perego GB, Lunati M, Curnis A, Guenzati G, Vicentini A, et al. Remote Monitoring Reduces Healthcare Use and Improves Quality of Care in Heart Failure Patients With Implantable Defibrillators. Circulation. 2012;125(24):2985–92.
17.
Boriani G, Da Costa A, Ricci RP, Quesada A, Favale S, Iacopino S, et al. The MOnitoring Resynchronization dEvices and CARdiac patiEnts (MORE-CARE) Randomized Controlled Trial: Phase 1 Results on Dynamics of Early Intervention With Remote Monitoring. Journal of Medical Internet Research. 2013;15(8):e167.
18.
AL‐KHATIB SM, PICCINI JP, KNIGHT D, STEWART M, CLAPP‐CHANNING N, SANDERS GD. Remote Monitoring of Implantable Cardioverter Defibrillators versus Quarterly Device Interrogations in Clinic: Results from a Randomized Pilot Clinical Trial. Journal of Cardiovascular Electrophysiology. 2010;21(5):545–50.
19.
López-Liria R, López-Villegas A, Enebakk T, Thunhaug H, Lappegård KT, Catalán-Matamoros D. Telemonitoring and Quality of Life in Patients after 12 Months Following a Pacemaker Implant: the Nordland Study, a Randomised Trial. International Journal of Environmental Research and Public Health. 2019;16(11):2001.
20.
McManus RJ, Mant J, Franssen M, Nickless A, Schwartz C, Hodgkinson J, et al. Efficacy of self-monitored blood pressure, with or without telemonitoring, for titration of antihypertensive medication (TASMINH4): an unmasked randomised controlled trial. The Lancet. 2018;391(10124):949–59.
21.
McManus RJ, Mant J, Bray EP, Holder R, Jones MI, Greenfield S, et al. Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial. The Lancet. 2010;376(9736):163–72.
22.
Green BB. Effectiveness of Home Blood Pressure Monitoring, Web Communication, and Pharmacist Care on Hypertension Control. JAMA. 2008;299(24):2857.
23.
Margolis KL, Asche SE, Bergdall AR, Dehmer SP, Groen SE, Kadrmas HM, et al. Effect of Home Blood Pressure Telemonitoring and Pharmacist Management on Blood Pressure Control. JAMA. 2013;310(1):46.
24.
McKinstry B, Hanley J, Wild S, Pagliari C, Paterson M, Lewis S, et al. Telemonitoring based service redesign for the management of uncontrolled hypertension: multicentre randomised controlled trial. BMJ. 2013;346(may24 4):f3030–f3030.
25.
Kim YN, Shin DG, Park S, Lee CH. Randomized clinical trial to assess the effectiveness of remote patient monitoring and physician care in reducing office blood pressure. Hypertension Research. 2015;38(7):491–7.
26.
Shea S, Weinstock RS, Teresi JA, Palmas W, Starren J, Cimino JJ, et al. A Randomized Trial Comparing Telemedicine Case Management with Usual Care in Older, Ethnically Diverse, Medically Underserved Patients with Diabetes Mellitus: 5 Year Results of the IDEATel Study. Journal of the American Medical Informatics Association. 2009;16(4):446–56.
27.
Wild SH, Hanley J, Lewis SC, McKnight JA, McCloughan LB, Padfield PL, et al. Supported Telemonitoring and Glycemic Control in People with Type 2 Diabetes: The Telescot Diabetes Pragmatic Multicenter Randomized Controlled Trial. PLOS Medicine. 2016;13(7):e1002098.
28.
Nicolucci A, Cercone S, Chiriatti A, Muscas F, Gensini G. A Randomized Trial on Home Telemonitoring for the Management of Metabolic and Cardiovascular Risk in Patients with Type 2 Diabetes. Diabetes Technology & Therapeutics. 2015;17(8):563–70.
29.
Jeong JY, Jeon JH, Bae KH, Choi YK, Park KG, Kim JG, et al. Smart Care Based on Telemonitoring and Telemedicine for Type 2 Diabetes Care: Multi-Center Randomized Controlled Trial. Telemedicine and e-Health. 2018;24(8):604–13.
30.
Lee JY, Chan CKY, Chua SS, Ng CJ, Paraidathathu T, Lee KKC, et al. Telemonitoring and Team-Based Management of Glycemic Control on People with Type 2 Diabetes: a Cluster-Randomized Controlled Trial. Journal of General Internal Medicine. 2019;35(1):87–94.
31.
Quinn CC, Shardell MD, Terrin ML, Barr EA, Ballew SH, Gruber-Baldini AL. Cluster-Randomized Trial of a Mobile Phone Personalized Behavioral Intervention for Blood Glucose Control. Diabetes Care. 2011;34(9):1934–42.
32.
RYAN F, BYRNE S, O’SHEA S. Randomized controlled trial of supervised patient self-testing of warfarin therapy using an internet-based expert system. Journal of Thrombosis and Haemostasis. 2009;7(8):1284–90.
33.
Pinnock H, Hanley J, McCloughan L, Todd A, Krishan A, Lewis S, et al. Effectiveness of telemonitoring integrated into existing clinical services on hospital admission for exacerbation of chronic obstructive pulmonary disease: researcher blind, multicentre, randomised controlled trial. BMJ. 2013;347(oct17 3):f6070–f6070.
34.
Téot L, Geri C, Lano J, Cabrol M, Linet C, Mercier G. Complex Wound Healing Outcomes for Outpatients Receiving Care via Telemedicine, Home Health, or Wound Clinic: A Randomized Controlled Trial. The International Journal of Lower Extremity Wounds. 2019;19(2):197–204.
35.
Lee TC, Kaiser TE, Alloway R, Woodle ES, Edwards MJ, Shah SA. Telemedicine Based Remote Home Monitoring After Liver Transplantation. Annals of Surgery. 2019;270(3):564–72.
36.
Kim BJ, Park JM, Park TH, Kim J, Lee J, Lee KJ, et al. Remote blood pressure monitoring and behavioral intensification for stroke: A randomized controlled feasibility trial. PLOS ONE. 2020;15(3):e0229483.
37.
Maiolo C, Mohamed EI, Fiorani CM, de Lorenzo A. Home telemonitoring for patients with severe respiratory illness: the Italian experience. Journal of Telemedicine and Telecare. 2003;9(2):67–71.
38.
Piotrowicz E, Pencina MJ, Opolski G, Zareba W, Banach M, Kowalik I, et al. Effects of a 9-Week Hybrid Comprehensive Telerehabilitation Program on Long-term Outcomes in Patients With Heart Failure. JAMA Cardiology. 2020;5(3):300.
39.
Piotrowicz E, Baranowski R, Bilinska M, Stepnowska M, Piotrowska M, Wójcik A, et al. A new model of home‐based telemonitored cardiac rehabilitation in patients with heart failure: effectiveness, quality of life, and adherence. European Journal of Heart Failure. 2010;12(2):164–71.
40.
Piotrowicz E, Zieliński T, Bodalski R, Rywik T, Dobraszkiewicz-Wasilewska B, Sobieszczańska-Małek M, et al. Home-based telemonitored Nordic walking training is well accepted, safe, effective and has high adherence among heart failure patients, including those with cardiovascular implantable electronic devices: a randomised controlled study. European Journal of Preventive Cardiology. 2014;22(11):1368–77.
41.
Peng X, Su Y, Hu Z, Sun X, Li X, Dolansky MA, et al. Home-based telehealth exercise training program in Chinese patients with heart failure. Medicine. 2018;97(35):e12069.
42.
Hwang R, Bruning J, Morris NR, Mandrusiak A, Russell T. Home-based telerehabilitation is not inferior to a centre-based program in patients with chronic heart failure: a randomised trial. Journal of Physiotherapy. 2017;63(2):101–7.
43.
Skobel E, Knackstedt C, Martinez-Romero A, Salvi D, Vera-Munoz C, Napp A, et al. Internet-based training of coronary artery patients: the Heart Cycle Trial. Heart and Vessels. 2016;32(4):408–18.
44.
Kraal JJ, Van den Akker-Van Marle ME, Abu-Hanna A, Stut W, Peek N, Kemps HM. Clinical and cost-effectiveness of home-based cardiac rehabilitation compared to conventional, centre-based cardiac rehabilitation: Results of the FIT@Home study. European Journal of Preventive Cardiology. 2017;24(12):1260–73.
45.
Batalik L, Dosbaba F, Hartman M, Batalikova K, Spinar J. Benefits and effectiveness of using a wrist heart rate monitor as a telerehabilitation device in cardiac patients. Medicine. 2020;99(11):e19556.
46.
Moffet H, Tousignant M, Nadeau S, Mérette C, Boissy P, Corriveau H, et al. In-Home Telerehabilitation Compared with Face-to-Face Rehabilitation After Total Knee Arthroplasty. The Journal of Bone and Joint Surgery-American Volume. 2015;97(14):1129–41.
47.
Hou J, Yang R, Yang Y, Tang Y, Deng H, Chen Z, et al. The Effectiveness and Safety of Utilizing Mobile Phone–Based Programs for Rehabilitation After Lumbar Spinal Surgery: Multicenter, Prospective Randomized Controlled Trial. JMIR mHealth and uHealth. 2019;7(2):e10201.
48.
Lo AC, Guarino PD, Richards LG, Haselkorn JK, Wittenberg GF, Federman DG, et al. Robot-Assisted Therapy for Long-Term Upper-Limb Impairment after Stroke. New England Journal of Medicine. 2010;362(19):1772–83.
49.
Paul L, Renfrew L, Freeman J, Murray H, Weller B, Mattison P, et al. Web-based physiotherapy for people affected by multiple sclerosis: a single blind, randomized controlled feasibility study. Clinical Rehabilitation. 2018;33(3):473–84.
50.
Gehring K, Kloek CJ, Aaronson NK, Janssen KW, Jones LW, Sitskoorn MM, et al. Feasibility of a home-based exercise intervention with remote guidance for patients with stable grade II and III gliomas: a pilot randomized controlled trial. Clinical Rehabilitation. 2017;32(3):352–66.
51.
Piraux E, Reychler G, Forget P, Yombi JC, Caty G. Feasibility and Preliminary Effects of a Telerehabilitation Program for People Living With HIV. Journal of the Association of Nurses in AIDS Care. 2019;30(2):176–85.
52.
Steventon A, Bardsley M, Billings J, Dixon J, Doll H, Hirani S, et al. Effect of telehealth on use of secondary care and mortality: findings from the Whole System Demonstrator cluster randomised trial. BMJ. 2012;344(jun21 3):e3874–e3874.
53.
Hirani SP, Rixon L, Cartwright M, Beynon M, Newman SP. The Effect of Telehealth on Quality of Life and Psychological Outcomes Over a 12-Month Period in a Diabetes Cohort Within the Whole Systems Demonstrator Cluster Randomized Trial. JMIR Diabetes. 2017;2(2):e18.
54.
Salisbury C, O’Cathain A, Thomas C, Edwards L, Gaunt D, Dixon P, et al. Telehealth for patients at high risk of cardiovascular disease: pragmatic randomised controlled trial. BMJ. 2016;i2647.
55.
Absolom K, Warrington L, Hudson E, Hewison J, Morris C, Holch P, et al. Phase III Randomized Controlled Trial of eRAPID: eHealth Intervention During Chemotherapy. Journal of Clinical Oncology. 2021;39(7):734–47.
56.
Cho JH, Kim HS, Yoo SH, Jung CH, Lee WJ, Park CY, et al. An Internet-based health gateway device for interactive communication and automatic data uploading: Clinical efficacy for type 2 diabetes in a multi-centre trial. Journal of Telemedicine and Telecare. 2016;23(6):595–604.
57.
Vesterby MS, Pedersen PU, Laursen M, Mikkelsen S, Larsen J, Søballe K, et al. Telemedicine support shortens length of stay after fast-track hip replacement. Acta Orthopaedica. 2016;88(1):41–7.
58.
Jakobsen AS, Laursen LC, Rydahl-Hansen S, Østergaard B, Gerds TA, Emme C, et al. Home-Based Telehealth Hospitalization for Exacerbation of Chronic Obstructive Pulmonary Disease: Findings from “The Virtual Hospital” Trial. Telemedicine and e-Health. 2015;21(5):364–73.
59.
Kashem A, Droogan M, Santamore W. Web-based Internet telemedicine management of patients with heart failure.
60.
Kashem A, Droogan MT, Santamore WP, Wald JW, Marble JF, Cross RC, et al. Web-Based Internet Telemedicine Management of Patients with Heart Failure. Telemedicine and e-Health. 2006;12(4):439–47.
61.
Jerant AF, Azari R, Nesbitt TS. Reducing the Cost of Frequent Hospital Admissions for Congestive Heart Failure. Medical Care. 2001;39(11):1234–45.
62.
Liang HY, Hann Lin L, Yu Chang C, Mei Wu F, Yu S. Effectiveness of a Nurse‐Led Tele‐Homecare Program for Patients With Multiple Chronic Illnesses and a High Risk for Readmission: A Randomized Controlled Trial. Journal of Nursing Scholarship. 2021;53(2):161–70.
63.
Janse A, Worm-Smeitink M, Bleijenberg G, Donders R, Knoop H. Efficacy of web-based cognitive–behavioural therapy for chronic fatigue syndrome: randomised controlled trial. The British Journal of Psychiatry. 2018;212(2):112–8.
64.
Nijhof SL, Bleijenberg G, Uiterwaal CS, Kimpen JL, van de Putte EM. Effectiveness of internet-based cognitive behavioural treatment for adolescents with chronic fatigue syndrome (FITNET): a randomised controlled trial. The Lancet. 2012;379(9824):1412–8.
65.
Andersson E, Enander J, Andrén P, Hedman E, Ljótsson B, Hursti T, et al. Internet-based cognitive behaviour therapy for obsessive–compulsive disorder: a randomized controlled trial. Psychological Medicine. 2012;42(10):2193–203.
66.
Anderson E, Parslow R, Hollingworth W, Mills N, Beasant L, Gaunt D, et al. Recruiting Adolescents With Chronic Fatigue Syndrome/Myalgic Encephalomyelitis to Internet-Delivered Therapy: Internal Pilot Within a Randomized Controlled Trial. Journal of Medical Internet Research. 2020;22(8):e17768.
67.
Salisbury C, O’Cathain A, Edwards L, Thomas C, Gaunt D, Hollinghurst S, et al. Effectiveness of an integrated telehealth service for patients with depression: a pragmatic randomised controlled trial of a complex intervention. The Lancet Psychiatry. 2016;3(6):515–25.
68.
Egede LE, Acierno R, Knapp RG, Lejuez C, Hernandez-Tejada M, Payne EH, et al. Psychotherapy for depression in older veterans via telemedicine: a randomised, open-label, non-inferiority trial. The Lancet Psychiatry. 2015;2(8):693–701.
69.
Böhm M, Drexler H, Oswald H, Rybak K, Bosch R, Butter C, et al. Fluid status telemedicine alerts for heart failure: a randomized controlled trial. European Heart Journal. 2016;37(41):3154–63.
70.
Reiss K, Andersen K, Pearson E, Biswas K, Taleb F, Ngo TD, et al. Unintended Consequences of mHealth Interactive Voice Messages Promoting Contraceptive Use After Menstrual Regulation in Bangladesh: Intimate Partner Violence Results From a Randomized Controlled Trial. Global Health: Science and Practice. 2019;7(3):386–403.
71.
Smith C, Ngo TD, Gold J, Edwards P, Vannak U, Sokhey L, et al. Effect of a mobile phone-based intervention on post-abortion contraception: a randomized controlled trial in Cambodia. Bulletin of the World Health Organization. 2015;93(12):842-850A.
72.
Ellison LM. Postoperative Robotic Telerounding. Archives of Surgery. 2007;142(12):1177.
73.
Schaub MP, Wenger A, Berg O, Beck T, Stark L, Buehler E, et al. A Web-Based Self-Help Intervention With and Without Chat Counseling to Reduce Cannabis Use in Problematic Cannabis Users: Three-Arm Randomized Controlled Trial. Journal of Medical Internet Research. 2015;17(10):e232.
74.
Meyer BC, Raman R, Hemmen T, Obler R, Zivin JA, Rao R, et al. Efficacy of site-independent telemedicine in the STRokE DOC trial: a randomised, blinded, prospective study. The Lancet Neurology. 2008;7(9):787–95.
75.
Demaerschalk BM, Bobrow BJ, Raman R, Kiernan TEJ, Aguilar MI, Ingall TJ, et al. Stroke Team Remote Evaluation Using a Digital Observation Camera in Arizona. Stroke. 2010;41(6):1251–8.
76.
Paul L, Coulter EH, Miller L, McFadyen A, Dorfman J, Mattison PGG. Web-based physiotherapy for people moderately affected with Multiple Sclerosis; quantitative and qualitative data from a randomized, controlled pilot study. Clinical Rehabilitation. 2014;28(9):924–35.
77.
Sekimoto S, Oyama G, Hatano T, Sasaki F, Nakamura R, Jo T, et al. A Randomized Crossover Pilot Study of Telemedicine Delivered via iPads in Parkinson’s Disease. Parkinson’s Disease. 2019;2019:1–7.
Citation
Copyright
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.